Search

everythinglearnresearchcommunity

for

Search:↓

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Minoxidil can help regrow hair in alopecia areata patients.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Dupilumab helps children with alopecia areata regrow hair safely.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Hair absorbs alkali bromide salts and water, affecting its structure, with absorption decreasing at higher temperatures.

This therapy effectively treats resistant alopecia areata with minimal side effects.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Generative AI tools like GPT-4o can effectively automate SALT scoring for alopecia areata, matching clinician accuracy.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Baricitinib is effective and safe for treating severe alopecia areata.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.